Cardiac Rhythm Management Devices Market -
Size, Share, Outlook, and Opportunity Analysis,
2018-2026
Cardiac Rhythm Management (CRM) devices include pacemakers (PMs), implantable
cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. These
devices perform various functions, including bradycardia pacing, cardiac resynchronization for
heart failure, monitoring for arrhythmias, defibrillation, and anti-tachycardia pacing for
tachyarrhythmia. Products such as cardiac resynchronization therapy can improve congestive
heart failure symptoms by improving the timing of the heart’s contractions, resulting in
pumping more blood to the body.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2364
The global cardiac rhythm management devices market size was valued at US$ 19.05 billion in
2017, and is expected to witness a CAGR of 7.5% over the forecast period (2018 – 2026).
Market Dynamics
Increasing incidences of heart failure and arrhythmia have fuelled rapid advancements in
cardiac rhythm management (CRM) technologies eventually increasing the demand for CRM
devices. According to the study published in 2016, by the Journal of the Formosan Medical
Association, around 72 million people are estimated to suffer from atrial fibrillation in Asia by
2050, which is expected to be more than double the combined numbers of patients from the
U.S. and Europe.
However, factors such as chances of infections associated with installation of pacemakers in
cardiac patients can hamper the cardiac rhythm management devices market growth. Pacemaker
surgery can also led to various complications such as bleeding, bruising or swelling at the of
area of pacemaker implantation leading to blood vessel or nerve damage, which in turn can
reduce adoption of cardiac implants in patients.